| Literature DB >> 30562948 |
Fanny Buckinx1,2, Gilles Gouspillou3,4, Livia P Carvalho5,6, Vincent Marcangeli7,8, Guy El Hajj Boutros9,10, Maude Dulac11, Philippe Noirez12,13, José A Morais14, Pierette Gaudreau15, Mylène Aubertin-Leheudre16,17.
Abstract
BACKGROUND: To compare the effects of high-intensity interval training (HIIT) alone vs. HIIT combined with L-citrulline (CIT) supplementation on functional capacity and muscle function in dynapenic-obese elderly.Entities:
Keywords: HIIT; aging; citrulline; dynapenia; functional capacities; muscle function; obesity
Year: 2018 PMID: 30562948 PMCID: PMC6306942 DOI: 10.3390/jcm7120561
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Citrulline and placebo nutrients composition.
| Citrulline (10 g) | Placebo (10 g) |
|---|---|
| 38 kcal | 38 kcal |
| 0 g of proteins | 0 g of proteins |
| 0 g of maltodextrin (carbohydrate) | 10 g of maltodextrin (carbohydrate) |
| 10 g of L-citrulline | 0 g of L-Citrulline |
Figure 1Flow chart of the Secondary-ANALYSIS study.
Characteristics and differences in body composition at baseline and after 12 weeks of intervention between groups.
| Variables | HIIT-CIT ( | HIIT-PLA ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Time Effect Adjusted for Age | Time × Group Effect Adjusted for Age | |||
| General characteristics | ||||||||
| Age (years) | 65.7 ± 4.2 | NA | NA | 68.1 ± 4.2 | NA | NA | NA | NA |
| Sex (% men) | 50 | NA | NA | 50 | NA | NA | NA | NA |
| MoCA (/30) | 27.1 ± 1.9 | NA | NA | 27.9 ± 1.4 | NA | NA | NA | NA |
| Body composition | ||||||||
| Body weight (BW; kg) | 82.6 ± 12.5 | 82.1 ± 10.9 | 0.40 | 83.7 ± 11.8 | 82.6 ± 12.5 | 0.30 | 0.35 | 0.98 |
| BMI (kg/m²) | 30.5 ± 4.1 | 30.4 ± 4.6 | 0.56 | 30.5 ± 4.9 | 30.0 ± 4.9 | 0.27 | 0.67 | 0.62 |
| WC (cm) | 107 ± 11 | 104 ± 11 | <0.001 | 106 ± 11 | 104 ± 10 | <0.001 | 0.20 | 0.15 |
| Total LM (kg) | 47.8 ± 7.4 | 48.2 ± 7.3 | 0.19 | 47.3 ± 9.2 | 47.9 ± 9.6 | 0.04 | 0.54 | 0.59 |
| Total FM (%) | 38.9 ± 5.8 | 37.8 ± 6.3 | 0.02 | 38.9 ± 6.3 | 38.5 ± 7.6 | 0.25 | 0.23 | 0.17 |
| Android FM (%) | 48.8 ± 5.5 | 47.7± 6.8 | 0.09 | 48.5 ± 6.6 | 48.1 ± 7.2 | 0.46 | 0.41 | 0.25 |
| Gynoid FM (%) | 40.4 ± 8.1 | 39.6 ± 8.8 | 0.19 | 41.1 ± 10.1 | 40.8 ± 10.2 | 0.55 | 0.42 | 0.46 |
| Leg FM (%) | 36.5 ± 9.0 | 35.5± 9.2 | 0.02 | 37.0 ± 10.7 | 36.5 ± 10.8 | 0.18 | 0.17 | 0.40 |
Data are presented as means ± SD. p ≤ 0.05: significant. NA: not applicable. Significant differences between HIIT-CIT and HIIT-PLA groups at baseline using t test significant differences. * significant intra-group differences between pre and post intervention using paired t test. Time (HIIT intervention) and time × group effects using repeated-measure ANCOVA (adjusted by age). BW = Body Weight; BMI = Body Mass Index; WC = waist circumference; LM = Lean Mass; FM = Fat Mass
Characteristics and differences on muscle function and functional capacities at baseline and after 12 weeks of intervention between groups.
| Variables | HIIT-CIT ( | HIIT-PLA ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Time Effect Adjusted for Age | Time × Group Effect Adjusted for Age | |||
| Functional & aerobic capacities | ||||||||
| TUGn (s) | 9.9 ± 1.3 | 8.7 ± 0.9 | <0.001 | 10.3 ± 1.8 | 9.1 ± 1.3 | <0.001 | 0.03 | 0.53 |
| TUGf (s) | 7.4 ± 0.8 | 6.2 ± 0.9 | <0.001 | 7.5 ± 1.1 | 6.6 ± 0.9 | <0.001 | 0.04 | 0.04 |
| 6 MWT (m) | 558 ± 92 | 633 ± 85 | <0.001 | 550 ± 85 | 618 ± 91 | <0.001 | 0.61 | 0.70 |
| Estimated VO2max (mL/min/kg) | 17.8 ± 2.1 | 19.5 ± 1.9 | <0.001 | 17.6 ± 2.1 | 19.2 ± 2.1 | <0.001 | 0.67 | 0.69 |
| Unipodal balance (/60 s) | 26.7 ± 18.6 | 40.5 ± 21.6 | 0.001 | 22.4 ± 14.6 | 34.5 ± 20.2 | <0.001 | 0.62 | 0.48 |
| Chair stand test (s) | 19.1 ± 3.3 | 15.1 ± 2.7 | <0.001 | 18.8 ± 3.7 | 15.6 ± 3.7 | <0.001 | 0.03 | 0.15 |
| Alternate step test ( | 30.3 ± 4.9 | 35.0 ± 5.6 | <0.001 | 28.9 ± 3.9 | 33.6 ± 4.7 | <0.001 | 0.59 | 0.56 |
| Muscle Function | ||||||||
| ULMS (kg) | 32.6 ± 9.1 | 35.7 ± 10.8 | <0.001 | 32.4 ± 8.1 | 33.5 ± 9.2 | 0.18 | 0.035 | 0.05 |
| ULMSr (Kg/Kg) | 0.39 ± 0.09 | 0.43 ± 0.11 | <0.001 | 0.39 ± 0.08 | 0.41 ± 0.08 | 0.09 | 0.019 | 0.05 |
| Upper MQ (kg/kg) | 6.20 ± 1.04 | 6.79 ± 1.19 | 0.004 | 6.11 ± 1.23 | 6.98 ± 4.50 | 0.21 | 0.19 | 0.98 |
| LLMS ( | 348 ± 83 | 379 ± 72 | 0.007 | 339 ± 92 | 347 ± 96 | 0.22 | 0.07 | 0.07 |
| LLMSr (kg/kg) | 0.42 ± 0.09 | 0.46 ± 0.08 | <0.001 | 0.42 ± 0.11 | 0.43 ± 0.09 | <0.001 | 0.10 | 0.14 |
| Lower MQ (kg/kg) | 2.11 ± 0.45 | 2.26 ± 0.35 | 0.004 | 2.06 ± 0.35 | 2.08 ± 0.31 | 0.15 | 0.11 | 0.10 |
| Muscle Power (W) | 153 ± 52 | 186 ± 56 | <0.001 | 155 ± 70 | 186 ± 69 | <0.001 | 0.84 | 0.90 |
Data are presented means ± SD. p ≤ 0.05: significant. NA: not applicable. Significant differences between HIIT-CIT and HIIT-PLA groups at baseline using t test significant differences. * significant intra-group differences between pre and post intervention using paired t test. Time (HIIT intervention) and time × group effects using repeated-measure ANCOVA (adjusted by age). TUG = Timed up and Go; 6MWT = 6 Min Walking Test; ULMS = Upper Limb Muscle Strength; ULMSr = Upper Limb Muscle Strength/ body weight; LLMS = Lower limb Muscle Strength; LLMSr = Lower limb Muscle Strength/body weight; MQ = Muscle Quality
Figure 2Evolution of ULMS (A), ULMSr (B) and TUGF (C) during the intervention in both groups. Significant differences between HIIT-CIT and HIIT-PLA groups at baseline using t test significant differences Time (HIIT intervention) and time × group effects using repeated-measure ANCOVA (adjusted by age). *: p < 0.05; ***: p < 0.0001. TUGF = fast-paced Timed up and Go; ULMS = Upper Limb Muscle Strength; ULMSr = Upper Limb Muscle Strength/ body weight.
Characteristics and differences in energy balance (potential confounder) at baseline and after 12 weeks of intervention between groups.
| Variables | HIIT-CIT ( | HIIT-PLA ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Time Effect Adjusted for Age | Time × Group Effect Adjusted for Age | |||
| Energy balance | ||||||||
| Total Kcal intake (kcal/day) | 1963 ± 310 | 1826 ± 540 | 0.36 | 2211 ± 1032 | 2055 ± 479 | 0.73 | 0.35 | 0.29 |
| Proteins intake (g/day) | 83.6 ± 20.7 | 87.3 ± 5.7 | 0.65 | 86.9 ± 30.5 | 79.6 ± 20.6 | 0.61 | 0.77 | 0.76 |
| Carbohydrates intake (g/day) | 252 ± 64 | 222 ± 76 | 0.24 | 267 ± 137 | 251 ± 52 | 0.79 | 0.25 | 0.22 |
| Lipids intake (g/day) | 69.6 ± 18.4 | 64.9 ± 26.3 | 0.28 | 90.2 ± 51.6 | 79.9 ± 23.7 | 0.65 | 0.24 | 0.26 |
| Number of steps ( | 6639 ± 3448 | 6110 ± 3334 | 0.88 | 6228 ± 3217 | 5501 ± 3468 | 0.27 | 0.23 | 0.18 |
Data are presented as means ± SD. p ≤ 0.05 significant. NA: not applicable. Significant differences between HIIT-CIT and HIIT-PLA groups at baseline using t test significant differences. * significant intra-group differences between pre and post intervention using paired t test. Time (HIIT intervention) and time×group effects using repeated-measure ANCOVA (adjusted for age).
Number of responders following the intervention.
| Variables | HIIT-CIT Group ( | HIIT-PLA Group ( | |||
|---|---|---|---|---|---|
| Δ Changes (%) | Responders (%) | Δ Changes (%) | Responders (%) | ||
| Body composition | |||||
| BMI | −0.6 ± 3.8 | 65.8 | −1.3 ± 6.6 | 53 | 0.62 |
| WC | −3.1 ± 2.3 | 92 | −2.1 ± 2.8 | 83 | 0.15 |
| Total LM | 0.9 ± 3.1 | 53.8 | 1.3 ± 3.4 | 63.3 | 0.59 |
| Total FM | −2.9 ± 6.0 | 73.3 | −0.9 ± 5.12 | 50 | 0.17 |
| Gynoid FM | −2.2 ± 7.4 | 53.8 | −0.7 ± 7.7 | 56.7 | 0.46 |
| Android FM | −2.6 ± 7.3 | 65.4 | −0.6 ± 5.1 | 46.7 | 0.25 |
| Legs FM | −2.9 ± 5.6 | 73.1 | −1.5 ± 6.9 | 63.3 | 0.40 |
| Functional & aerobic capacities | |||||
| TUGn (%) | −12.3 ± 5.8 | 96.2 | −10.8 ± 10.9 | 90 | 0.53 |
| TUGf (%) | −16.1 ± 9.0 | 100 | −11.8 ± 7.8 | 93.3 | 0.04 * |
| 6MWT (%) | 14.5 ± 11.6 | 92.3 | 13.2 ± 13.3 | 93.3 | 0.70 |
| Estimated Vo2max | 10.2 ± 8.1 | 92.3 | 9.3 ± 9.3 | 93.3 | 0.69 |
| Unipedal balance | 109.1 ± 174.0 | 80.8 | 82.9 ± 96.1 | 86.7 | 0.48 |
| Chair Stand test | −20.5 ± 8.5 | 100 | −17.1 ± 8.8 | 96.6 | 0.15 |
| Alternate step test | 16.1 ± 7.2 | 100 | 17.4 ± 9.5 | 100 | 0.56 |
| Muscle function | |||||
| ULMS | 9.3 ± 10.8 | 82.3 | 3.3 ± 11.5 | 53.3 | 0.04 * |
| Relative ULMS | 10.9 ± 11.6 | 80.8 | 5.3 ± 16.0 | 56.7 | 0.018 * |
| UMQ | 10.4 ± 15.5 | 76.9 | 10.7 ± 37.3 | 60 | 0.98 |
| LLMS | 12.3 ± 21.5 | 80.8 | 3.3 ± 12.1 | 58.3 | 0.07 * |
| Relative LLMS | 13.9 ± 22.3 | 80.8 | 5.6 ± 16.4 | 62.5 | 0.10 |
| LMQ | 10.8 ± 22.7 | 73.1 | 1.9 ± 12.6 | 54.2 | 0.17 * |
| Muscle Power | 26.6 ± 30.7 | 80.8 | 25.7 ± 25.3 | 89.7 | 0.90 |
Data are presented as means ± SD. Delta change calculation (%): ((post-pre)/pre) × 100. p ≤ 0.05: significant using Man-Whitney tests. * change considered clinically significant. WC = waist circumference; BMI = Body Mass Index; LM = Lean Mass; FM = Fat Mass; TUG = Timed up and Go; 6MWT = 6 Min Walking Test; ULMS = Upper Limb Muscle Strength; UMQ = Upper Muscle Quality; LLMS = Lower Limb Muscle Strength; LMQ = Lower limb Muscle Quality.